Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | acetyl-CoA carboxylase ACC1 | 0.0388 | 1 | 1 |
Schistosoma mansoni | acetyl-CoA carboxylase | 0.0388 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.0214 | 0.4815 | 0.4815 |
Toxoplasma gondii | acetyl-coA carboxylase ACC2 | 0.0388 | 1 | 1 |
Loa Loa (eye worm) | carboxyl transferase domain-containing protein | 0.0374 | 0.9595 | 1 |
Leishmania major | methylcrotonoyl-coa carboxylase biotinylated subunitprotein-like protein | 0.0148 | 0.2839 | 0.2839 |
Trypanosoma brucei | acetyl-CoA carboxylase | 0.0388 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0214 | 0.4815 | 0.4815 |
Echinococcus multilocularis | propionyl coenzyme A carboxylase alpha chain | 0.0148 | 0.2839 | 0.2839 |
Trypanosoma cruzi | acetyl-CoA carboxylase | 0.024 | 0.5594 | 1 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0148 | 0.2839 | 0.2839 |
Schistosoma mansoni | pyruvate carboxylase | 0.0148 | 0.2839 | 0.2839 |
Wolbachia endosymbiont of Brugia malayi | Acetyl/propionyl-CoA carboxylase, alpha subunit | 0.0148 | 0.2839 | 1 |
Plasmodium falciparum | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.028 | 0.6803 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.0214 | 0.4815 | 0.4896 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0148 | 0.2839 | 0.2839 |
Entamoeba histolytica | acetyl-coA carboxylase, putative | 0.0066 | 0.0405 | 0.5 |
Mycobacterium tuberculosis | Probable pyruvate carboxylase Pca (pyruvic carboxylase) | 0.0148 | 0.2839 | 1 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.0148 | 0.2839 | 0.2839 |
Plasmodium vivax | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.028 | 0.6803 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0214 | 0.4815 | 0.4896 |
Chlamydia trachomatis | biotin carboxylase | 0.0134 | 0.2433 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.0214 | 0.4815 | 0.4815 |
Leishmania major | acetyl-CoA carboxylase, putative | 0.0388 | 1 | 1 |
Giardia lamblia | Acetyl-CoA carboxylase/pyruvate carboxylase fusion protein, putative | 0.0066 | 0.0405 | 0.5 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0214 | 0.4815 | 0.4815 |
Mycobacterium leprae | Probable bifunctional protein acetyl-/propionyl-coenzyme A carboxylase, alpha chain AccA3 (BccP) | 0.0148 | 0.2839 | 1 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain, AccA2 | 0.0148 | 0.2839 | 1 |
Echinococcus granulosus | propionyl coenzyme A carboxylase alpha chain | 0.0148 | 0.2839 | 0.2839 |
Echinococcus granulosus | acetylcholinesterase | 0.0214 | 0.4815 | 0.4815 |
Brugia malayi | Carboxylesterase family protein | 0.0214 | 0.4815 | 0.4896 |
Echinococcus granulosus | carboxylesterase 5A | 0.0214 | 0.4815 | 0.4815 |
Mycobacterium ulcerans | pyruvate carboxylase | 0.0148 | 0.2839 | 1 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.0148 | 0.2839 | 0.2839 |
Mycobacterium tuberculosis | Probable acetyl-/propionyl-coenzyme A carboxylase alpha chain (alpha subunit) AccA2: biotin carboxylase + biotin carboxyl carrie | 0.0148 | 0.2839 | 1 |
Trypanosoma brucei | unspecified product | 0.0097 | 0.1329 | 0.1329 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0214 | 0.4815 | 0.4896 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain AccA1 | 0.0148 | 0.2839 | 1 |
Echinococcus multilocularis | acetyl coenzyme A carboxylase 1 | 0.0388 | 1 | 1 |
Mycobacterium ulcerans | bifunctional protein acetyl-/propionyl-coenzyme a carboxylase (alpha chain) AccA3 | 0.0148 | 0.2839 | 1 |
Brugia malayi | Carboxyl transferase domain containing protein | 0.0374 | 0.9595 | 1 |
Toxoplasma gondii | pyruvate carboxylase | 0.0148 | 0.2839 | 0.2839 |
Brugia malayi | Carboxylesterase family protein | 0.0214 | 0.4815 | 0.4896 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.0148 | 0.2839 | 0.5074 |
Echinococcus granulosus | acetylcholinesterase | 0.0214 | 0.4815 | 0.4815 |
Loa Loa (eye worm) | hypothetical protein | 0.0214 | 0.4815 | 0.4896 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.0148 | 0.2839 | 0.5074 |
Leishmania major | carboxylase, putative | 0.0148 | 0.2839 | 0.2839 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.1475 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845] | ChEMBL. | No reference |
Potency (binding) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375] | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.